Sandoz Group AG (D8Y)
FSX
Closed
Aug 25, 2026
Day's Range
77.8452 wk Range
47.41Overview - D8Y - Sandoz Group AG
Key Statistics
Valuation
Enterprise Value
32.43B
P/E (Trailing)
‪61.77‬
Price / Sales (TTM)
‪2.88‬
Price / Book
‪4.39‬
EV / EBITDA
‪24.06‬
Profitability
Profit Margin
‪5.53%‬
Operating Margin
‪4.25%‬
Return on Assets
‪3.06%‬
Return on Equity
‪7.24%‬
Ownership
Shares Outstanding
432.69M
Float
416.43M
Held by Insiders
‪4.18%‬
Held by Institutions
‪50.55%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪74.12‬
200-Day Avg
‪69.03‬
Dividends
Payout Ratio
‪68.81%‬
Market Cap - D8Y - Sandoz Group AG
Peers - D8Y - Sandoz Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- D8YFSXSandoz Group AG33.93BMarket Cap+31.25%52-week change62.74P/E (Trailing)‪5.53%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation107.87BMarket Cap+24.53%52-week change35.09P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.12BMarket Cap+22.72%52-week change23.68P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR59.12BMarket Cap+20.59%52-week change23.25P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG42.67BMarket Cap+18.23%52-week change58.15P/E (Trailing)‪14.57%‬Profit Margin
- H6D0FSXHaleon plc37.44BMarket Cap+2.56%52-week change20.06P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - D8Y - Sandoz Group AG
About
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patients worldwide. The company develops, manufactures, and commercializes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
